ASU professor outlines importance of including sex chromosomes in genetic screenings (opens in new tab)

If a doctor wants to assess a patient’s risk for getting a whole range of diseases, from cystic fibrosis to cancer, they have the incredible ability to do so by looking at the patient’s unique set of genes in a process called genetic screening.But Melissa Wilson, an adjunct professor in the School of Life Sciences and a principal investigator with the National Institutes of Health, says that genetic screenings often overlook an important part of the human genome: the sex chromosomes.